Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation.

Segovia, Javier; Gerosa, Gino; Almenar, Luis; Livi, Ugolino; Viganò, Mario; Arizón, Jose Maria; Yonan, Nizar; Di Salvo, Thomas G; Renlund, Dale G; Kobashigawa, Jon A

Segovia, Javier; Gerosa, Gino; Almenar, Luis; Livi, Ugolino; Viganò, Mario; Arizón, Jose Maria; Yonan, Nizar; Di Salvo, Thomas G; Renlund, Dale G; Kobashigawa, Jon A.

Affiliation

Segovia J; Unidad de Transplante Cardiaco, Hospital Universitario Puerta de Hierro, Madrid, Spain. jsecu@eresmas.net

Clin Transplant ; 22(6): 809-14, 2008.

Article in En | MEDLINE | ID: mdl-18702660

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/administration & dosage; Graft Rejection/drug therapy; Graft Survival/drug effects; Heart Transplantation; Mycophenolic Acid/analogs & derivatives; Adult; Dose-Response Relationship, Drug; Female; Graft Rejection/mortality; Humans; Male; Middle Aged; Mycophenolic Acid/administration & dosage; Postoperative Complications; Single-Blind Method; Tablets, Enteric-Coated/administration & dosage; Therapeutic Equivalency; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Heart Transplantation / Graft Rejection / Graft Survival / Mycophenolic Acid Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2008 Document type: Article Affiliation country: Spain Country of publication: Denmark

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google